• About us
    • Profile
    • Contributors
    • Staff
    • Address
    • Contact Us
  • Articles
    • Canada
    • USA
    • International
  • Topics
    • Access to Medicines
    • Innovation
    • Comparative Effectiveness
    • Health Technology Assessment
    • Importation
    • Global Public Health
    • Emerging Markets
    • Patient Safety
    • Patient Advocacy
  • Events
  • Publications
    • Presentations
    • Reports and Research Papers
  • Register
Home


patient safety
1. WHO’s South East Asian Region (SEAR) May Not See Eye to Eye with WHO & EU on IP Rights
2. At least Two-Thirds of Foreign Drug Manufacturers that Export to the U.S. Have Never Been Inspected by the FDA
3. Sales of Imported Drugs Drop 80 Percent as Americans Abandon Risky Drug Importation
4. As lawmakers consider making it easier to import foreign drugs nearly two-thirds of Americans lack confidence in foreign manufactured prescription drugs
5. Encouraging consumers to import foreign drugs puts american patients at risk
6. Despite significant increases in drug utilization, hospitalizations for adverse effects have declined in Canada
7. Slower drug approval times do not improve patient safety
8. H.H.S. report on drug importation concludes that there are significant risks associated with importing drugs for personal use
9. State-sanctioned drug importation websites demonstrate problems regulating quality, safety and patient privacy standards of foreign pharmacies
10. Circumventing drug supply and distribution regulations to import prescription drugs puts patients at risk
Powered by Tags for Joomla
 

Top Topics

  • access to medicines
  • canada
  • chronic disease
  • disease management
  • health policy
  • health spending
  • importation
  • innovation
  • patient safety
  • usa

Latest News

  • Gates Foundation donates $10 Billion in call for decade of vaccines
  • Chronic disease prevention and health promotion
  • Global partnerships facilitate access to medicines
  • Commentary re FT article - Neglected Diseases Less Neglected
  • WHO’s South East Asian Region (SEAR) May Not See Eye to Eye with WHO & EU on IP Rights

Popular Articles

  • Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
  • Case studies for global health
  • Global partnerships facilitate access to medicines
  • 2008 UNAIDS report highlights decrease in global rate of infections; role of life-saving drugs
  • Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
 

Social Media

Follow whadvocacy on Twitter

linkedin_badge

facebook_badge

Login




  • Forgot your password?
  • Forgot your username?
  • Create an account

Who's Online

We have 467 guests and 1 member online

Latest Events

Thu Mar 11
US House Subcommittee on Africa and Global Health Hearing
copyright © World Health Advocacy Inc.